Percutaneous Intervention and Anticoagulation Outcome of Urgent and Elective Percutaneous Coronary Interventions After Pharmacologic Reperfusion With Tenecteplase Combined With Unfractionated Heparin, Enoxaparin, or Abciximab

Christophe L. Dubois, MD,* Ann Belmans, MSC,*† Christopher B. Granger, MD, FACC,‡ Paul W. Armstrong, MD, FACC,§ Lars Wallentin, MD, FACC, Paolo M. Fioretti, MD, FACC,¶ José L. López-Sendón, MD, FACC,# Freek W. Verheugt, MD, FACC,** Jürgen Meyer, MD, FACC,†† Frans Van de Werf, MD, FACC,* on behalf of the ASSENT-3 Investigators Leuven, Belgium; Durham, North Carolina; Edmonton, Canada; Uppsala, Sweden; Udine, Italy; Madrid, Spain; Nijmegen, The Netherlands; and Mainz, Germany